KL2TR001999 Gilmore ReFOCUS
Research Question:
cancer study
Basic Study Information
Purpose:
The purpose of the study is to examine the feasibility and safety of twelve weeks
oral supplementation of Epigallocatechin-3-gallate (EGCG) in older survivors of cancer
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Nikesha Gilmore
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search